The DOI matches its Crossref record; 28 of the 29 references it cites were found in a registry or an index.
Beat-to-beat variability of QT intervals is increased in patients with drug-induced long-QT syndrome: a case control pilot study
Abstract
AIMS: Torsades de pointes arrhythmias (TdP) occur by definition in the setting of prolonged QT intervals. Animal models of drug induced Long-QT syndrome (dLQTS) have shown higher predictive value for proarrhythmia with beat-to-beat variability of repolarization duration (BVR) when compared with QT intervals. Here, we evaluate variability of QT intervals in patients with a history of drug-induced long QT syndrome (dLQTS) and TdP in absence of a mutation in any of the major LQTS genes. METHODS AND RESULTS: Twenty patients with documented TdP under drugs with QT-prolonging potential were compared with 20 matched control individuals. An observer blinded to diagnosis manually measured lead-II, RR, and QT intervals from 30 consecutive beats. BVR was determined from Poincaré plots of QT intervals as short-term variability (STV(QT) = Sigma|QT(n)(+1) - QT(n)|/[30 x radical2]). QRS interval and cycle length was comparable between study groups and controls. No difference was found in QTc between dLQTS and controls (428 +/- 25 vs. 421 +/- 34 ms, P = 0.26), whereas STV(QT) was significantly higher in dLQTS when compared with controls (8.1 +/- 3.7 vs. 3.6 +/- 1.3 ms, P = 0.001). Proarrhythmic predictive power of STV(QT) was superior to that of the QTc interval (AUC: 0.89 vs. 0.57, 95% CI: 0.79-0.99 vs. 0.39-0.75). CONCLUSION: In the absence of QTc prolongation, baseline STV(QT) characterized patients with documented drug-induced proarrhythmia. STV(QT) could prove to be a useful non-invasive, easily obtainable parameter aiding the identification of the patient at risk for potentially life threatening arrhythmia in the context of drugs with QT prolonging potential.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Short-term beat-to-beat variability of QT intervals was found to be increased in patients with drug-induced long-QT syndrome and was suggested to use for the identification of patients at risk for potentially life-threatening arrhythmias.38”
From The Year of 2008 in Electrocardiology (2010) · cites this paper as [38]
Citations
Cites
Drug-induced prolongation of the QT interval
Roden, D. M. (2004) · New England Journal of Medicine · doi:10.1056/nejmra032426 · Cited by 1,965
hERG potassium channels and cardiac arrhythmia
Sanguinetti, M. C., & Tristani‐Firouzi, M. (2006) · Nature · doi:10.1038/nature04710 · Cited by 1,582
Spectrum of Mutations in Long-QT Syndrome Genes
Splawski, I., Shen, J., Timothy, K. W., Lehmann, M. H., Priori, S. G., Robinson, J. L., Moss, A. J., Schwartz, P. J., Towbin, J. A., Vincent, G. M., et al. (2000) · Circulation · doi:10.1161/01.cir.102.10.1178 · Cited by 1,231
Electrical Alternans and Vulnerability to Ventricular Arrhythmias
ROSENBAUM, D. S., Jackson, L. E., Smith, J. M., Garan, H., Ruskin, J. N., & Cohen, R. J. (1994) · New England Journal of Medicine · doi:10.1056/nejm199401273300402 · Cited by 1,141
KORA - A Research Platform for Population Based Health Research
Holle, R., Happich, M., Löwel, H., & Wichmann, H. ‐. (2005) · Das Gesundheitswesen · doi:10.1055/s-2005-858235 · Cited by 753
Self-citationTaking the “Idio” out of “Idiosyncratic”: Predicting Torsades de Pointes
Roden, D. M. (1998) · Pacing and Clinical Electrophysiology · doi:10.1111/j.1540-8159.1998.tb00148.x · Cited by 662
The Measurement of the Q-T Interval of the Electrocardiogram
Lepeschkin, E., & Surawicz, B. (1952) · Circulation · doi:10.1161/01.cir.6.3.378 · Cited by 628
Beat-to-Beat QT Interval Variability
Berger, R. D., Kasper, E. K., Baughman, K. L., Marbán, E., Calkins, H. G., & Tomaselli, G. F. (1997) · Circulation · doi:10.1161/01.cir.96.5.1557 · Cited by 613
Schwartz, P. J., & Malliani, A. (1975) · American Heart Journal · doi:10.1016/0002-8703(75)90008-3 · Cited by 526
Hondeghem, L. M., Carlsson, L. G., & Duker, G. (2001) · Circulation · doi:10.1161/01.cir.103.15.2004 · Cited by 500
Cited by
Sorted by citations
Items 101–126 of 126
Ohmuta, T., Kasao, M., Ono, T., Mitsui, K., & Shibata, N. (2014) · Japanese Journal of Electrocardiology · doi:10.5105/jse.34.213
Paavola, J. (2014) · Työväentutkimus Vuosikirja
Torsades de Pointes in the Guinea-Pig Heart
Soltysinska, E., & Thomsen, M. B. (2012) · Cardiovascular Drugs and Therapy · doi:10.1007/s10557-012-6417-x
Self-citationProbing cardiac repolarization reserve in drug safety assessment
Nalos, L. (2011) · Utrecht University Repository (Utrecht University)
Vahedi, F. (2013) · Gothenburg University Publications Electronic Archive (Gothenburg University)
How can we stabilize QT variability?
Morita, H. (2011) · Heart Rhythm · doi:10.1016/j.hrthm.2011.04.018
Zhu, Y. C., Yang, X., Wang, Z., & Peng, Y. (2013) · Computing in cardiology
München, L.-M.-U., & Steinbeck, G. (2008)
Self-citationThe effect of tachycardic irregularity on ventricular repolarization dynamics
Prinsen, J. K. (2013) · Michigan State University Libraries · doi:10.25335/m5175p
Dunnink, A. (2016) · Utrecht University Repository (Utrecht University)
Drug-Induced Long QT Syndrome - Clinical and Analytical Aspects for Medical Examiners
Morley, S. R. (2012) · Academic Forensic Pathology · doi:10.23907/2012.036
Assessing the Normal Value of STV-QT
Ohmuta, T., Kasao, M., Nakazawa, A., Ono, T., Mitsui, K., & Shibata, N. (2015) · Japanese Journal of Electrocardiology · doi:10.5105/jse.35.177
Ventricular arrhythmias in the remodeled heart: focus on risk prediction and monitoring
Sprenkeler, D. J. (2018) · Utrecht University Repository (Utrecht University)
Oxytocin Exerts Harmful Cardiac Repolarization Prolonging Effects in Drug-Induced LQTSPreprint
Kreifels, P., Bódi, I., Hornyik, T., Franke, G., Perez‐Feliz, S., Lewetag, R. D., Moss, R., Castiglione, A., Ziupa, D., Zehender, M., et al. (2021) · SSRN Electronic Journal · doi:10.2139/ssrn.3975629
Current awareness: Pharmacoepidemiology and drug safety
(2008) · Pharmacoepidemiology and Drug Safety · doi:10.1002/pds.1489
Gillis, A. M. (2012) · Elsevier eBooks · doi:10.1016/b978-1-4377-0285-9.00054-5
Loen, V., Smoczyńska, A., Hernandez, A. A., Scheerder, C. O. S., van der Linde, B. H. R., Beekman, H. D. M., Cervera-Barea, A., Boink, G. J. J., Sluijter, J. P. G., van der Heyden, M. A. G., et al. (2023) · EP Europace · doi:10.1093/europace/euad341
Self-citationHornyik, T., Husti, Z., & Baczkó, I. (2023) · Cardiologia Hungarica · doi:10.26430/chungarica.2023.53.5.419
Briston, S. J., Eisner, D. A., Dibb, K. M., Venetucci, L. A., & Trafford, A. W. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.05.09.723211
Hernandez, A. A., Meine, M., & Vos, M. A. (2026) · Heart Rhythm O2 · doi:10.1016/j.hroo.2026.06.005
Self-citationLong QT syndrome : studies of diagnostic methods
Diamant, U. (2013) · KTH Publication Database DiVA (KTH Royal Institute of Technology)
Metadata
- Authors
- Hinterseer, M., Thomsen, M. B., Beckmann, B.-M., Pfeufer, A., Schimpf, R., Wichmann, H.-E., Steinbeck, G., Vos, M. A., & Kaab, S.
- Affiliations
- LMU Klinikum (DE)
- Helmholtz Munich (DE)
- University Medical Centre Mannheim (DE)
- Corresponding author
- Hinterseer, M.
- Venue
- European Heart Journal
- Publisher
- Oxford University Press (OUP)
- Published
- 2007-12-12
- Volume
- 29
- Issue
- 2
- Pages
- 185-190
- ISSN
- 0195-668X (ISSN-L)
- 1522-9645
- OpenAlex
- W2067418531
- Cited by
- 126
- References
- 29
- Citations by year
- 2026: 4 · 2025: 3 · 2024: 1 · 2023: 3 · 2022: 6 · 2021: 4 · 2020: 6 · 2019: 5 · 2018: 2 · 2017: 8 · 2016: 5 · 2015: 8 · 2014: 8 · 2013: 12 · 2012: 10
- FWCI
- 6.55
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- European Heart Journal (publishedVersion)
- PubMed (publishedVersion)
- Research at the University of Copenhagen (University of Copenhagen) (publishedVersion)
- mediaTUM – the media and publications repository of the Technical University Munich (Technical University Munich) (submittedVersion)
- Site cant be reached (submittedVersion)
- Topics
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiac electrophysiology and arrhythmias
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Heart Rate Variability and Autonomic Control
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiac pacing and defibrillation studies
- Keywords
- drug-induced long QT syndrome, torsades de pointes, drug-induced arrhythmia, QTc prolongation, Poincaré plot, short-term variability, QT-prolonging drugs, risk stratification
- MeSH terms
- Aged, Arrhythmias, Cardiac, Disease Susceptibility, Electrocardiography, Female, Heart Rate, Humans, Long QT Syndrome, Male, Middle Aged, Pilot Projects, Predictive Value of Tests, Case-Control Studies, Torsades de Pointes
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review